IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BELVISI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.345
NA - Nord America 9.992
AS - Asia 9.925
SA - Sud America 807
AF - Africa 201
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 15
Totale 31.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.672
CN - Cina 3.179
SG - Singapore 2.654
GB - Regno Unito 2.569
IT - Italia 2.350
DE - Germania 1.263
SE - Svezia 1.058
HK - Hong Kong 886
RU - Federazione Russa 813
VN - Vietnam 721
IN - India 584
BR - Brasile 580
FR - Francia 538
TR - Turchia 383
BD - Bangladesh 379
NL - Olanda 370
KR - Corea 331
IE - Irlanda 274
FI - Finlandia 252
JP - Giappone 252
UA - Ucraina 228
CA - Canada 192
DK - Danimarca 146
ID - Indonesia 135
CI - Costa d'Avorio 94
EU - Europa 94
ES - Italia 76
AR - Argentina 66
CH - Svizzera 64
BE - Belgio 58
CO - Colombia 58
MX - Messico 58
IQ - Iraq 54
PH - Filippine 54
TW - Taiwan 47
AU - Australia 43
IR - Iran 43
PL - Polonia 43
EC - Ecuador 37
GR - Grecia 37
ZA - Sudafrica 31
AT - Austria 29
LV - Lettonia 29
UZ - Uzbekistan 29
PK - Pakistan 28
CZ - Repubblica Ceca 27
TH - Thailandia 22
RO - Romania 20
JO - Giordania 19
PT - Portogallo 19
CL - Cile 18
MA - Marocco 17
SA - Arabia Saudita 17
VE - Venezuela 16
MY - Malesia 15
HU - Ungheria 14
NO - Norvegia 14
JM - Giamaica 13
PY - Paraguay 13
CR - Costa Rica 12
IL - Israele 12
KZ - Kazakistan 12
KE - Kenya 11
NP - Nepal 11
BO - Bolivia 10
TT - Trinidad e Tobago 10
AE - Emirati Arabi Uniti 9
NZ - Nuova Zelanda 9
AZ - Azerbaigian 8
OM - Oman 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
HR - Croazia 7
SC - Seychelles 7
SI - Slovenia 7
TN - Tunisia 7
EG - Egitto 6
KW - Kuwait 6
LT - Lituania 6
AL - Albania 5
CY - Cipro 5
EE - Estonia 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
GT - Guatemala 4
HN - Honduras 4
NG - Nigeria 4
PE - Perù 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MD - Moldavia 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
Totale 31.377
Salva come PNG Salva come JPEG
Città #
Southend 2.198
Singapore 1.478
Ashburn 1.015
Chandler 893
Milan 871
Hong Kong 749
San Jose 573
Beijing 551
Seattle 490
Dallas 339
Princeton 336
Wilmington 330
Council Bluffs 321
Fairfield 317
Los Angeles 288
Dublin 272
Ann Arbor 268
Hanover 261
Hefei 224
Ho Chi Minh City 206
Hanoi 195
Woodbridge 194
Shanghai 185
Mountain View 174
Houston 171
Nanjing 171
Munich 168
Dearborn 167
Lauterbourg 163
Phoenix 163
Bengaluru 160
Santa Clara 157
New York 154
Boardman 138
Moscow 136
Frankfurt am Main 128
Redmond 125
Tokyo 124
Jacksonville 116
Des Moines 115
Redwood City 111
Cambridge 109
Guangzhou 105
Rome 105
Buffalo 104
Hangzhou 97
Abidjan 94
Shenyang 91
Seoul 88
Helsinki 85
Jakarta 80
Andover 73
Sakarya 68
São Paulo 67
Jinan 65
Mumbai 64
Medford 62
Somerville 60
Toronto 58
Istanbul 56
Cangzhou 54
Tianjin 54
Eitensheim 52
Changsha 51
Bogotá 48
Brussels 48
Bologna 47
Serra 45
Hebei 44
The Dalles 44
Chicago 42
Columbus 42
Nanchang 41
Berlin 40
Turku 40
Haiphong 37
San Diego 35
Grafing 34
Orem 33
Parma 33
Atlanta 32
Bitonto 32
Kent 32
Turin 32
London 31
Ningbo 31
Wuhan 31
Amsterdam 30
Bühl 30
Warsaw 30
Zhengzhou 29
Brooklyn 28
Da Nang 28
Nuremberg 28
Washington 28
Athens 25
Montreal 25
Shenzhen 25
Kunming 24
San Francisco 24
Totale 18.165
Salva come PNG Salva come JPEG
Nome #
αvβ3 integrin-targeted peptide/peptidomimetic-drug conjugates: in-depth analysis of the linker technology 688
Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs 560
Side chain effect in the modulation of αvβ3/α5β1 integrin activity via clickable isoxazoline-RGDmimetics: development of molecular delivery systems 462
New beta-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins 410
Crystal structure of human E-cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interaction 376
Innovative linker strategies for tumor‐targeted drug conjugates 359
Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods 346
New SMAC mimetic compounds as apoptosis inducers 325
Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies 319
Second generation of Fucose-based DC-SIGN ligands : affinity improvement and specificity versus Langerin 317
β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate 311
Insights into the Binding of Cyclic RGD Peptidomimetics to a5b1 Integrin by using Live-Cell NMR And Computational Studies 305
A Tight Contact: the Expanding Application of Salicylaldehydes in Lysine-targeting Covalent Drugs 303
A Trifunctional Self-Immolative Spacer Enables Drug Release with Two Non-Sequential Enzymatic Cleavages 302
Tumor targeting with an isoDGR-Drug conjugate 292
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions 291
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate 285
Functionalized azabicycloalkane amino acids by nitrone 1,3-dipolar intramolecular cycloaddition 279
Design and synthesis of peptidomimetic molecules targeting cadherin-mediated protein-protein interactions 279
Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin αVβ3 275
Synthesis of functionalized azabicycloalkane amino acids as dipeptide mimics 274
A critical assessment of force field accuracy against NMR data for cyclic peptides containing β-amino acids 264
Complete characterization of extracts of Onopordum illyricum L (Asteraceae) by HPLC/PDA/ESIMS and NMR 254
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αVβ3 254
Design of SMAC-Diablo Mimics Targeting XIAP/BIR3 Domain for Apoptosis Induction: a Computational Study. 249
A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells 249
Synthesis, characterization, and biological evaluation of a dual-action ligand targeting αvβ3 integrin and VEGF receptors 248
Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors 246
Functionalized 2-Hydroxybenzaldehyde-PEG Modules as Portable Tags for the Engagement of Protein Lysine ϵ-Amino Groups 245
Thermodynamically-Weighted Conformational Ensemble of Cyclic RGD Peptidomimetics from NOE Data 244
Dual-action ligand targeting both integrin αvβ3 and VEGF receptors 232
Investigating the Interaction of Cyclic RGD Peptidomimetics with αVβ6 Integrin by Biochemical and Molecular Docking Studies 232
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ 3 integrin ligands 230
Synthesis and biological evaluation (in Vitro and in Vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αvβ3 228
New homo- and heretodimeric SMAC mimetic compound as apoptosis inducers 228
Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids 227
Advanced Pyrrolidine-Carbamate Self-Immolative Spacer with Tertiary Amine Handle Induces Superfast Cyclative Drug Release 226
A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl-Substituted Azabicycloalkane Amino Acids 226
Synthesis and Conformational Analysis of a α-Man-(1→2)-α-Man-(1→6)-α-Man Mimic 225
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 222
Modelling cadherin-mediated protein-protein interactions by atomistic simulations 220
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands 219
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II : Structural and biological characterization 218
Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-beta-ACPC) Scaffolds 218
Stereoselective synthesis of 6,5-bicyclic reverse-turn peptidomimetics 214
Modellistica computazionale di peptidomimetici modulatori di interazioni proteina-proteina 212
New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics 211
Potent integrin ligands containing a bifunctional diketopiperazine scaffold 210
Targeting Integrin alpha(V)beta(3) with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario 210
Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 208
Synthesis of cyclic RGD peptidomimetics, containing a bifunctional diketopiperazine scaffold, as new integrin ligands 205
Cyclic Peptide Integrin Derivatives for Use as Anticancer Agents 205
Nuovi composti antitumorali 205
Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma 203
Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting 201
Synthesis of Gd and [68Ga] complexes in conjugation with a conformationally-optimized RGD sequence as potential MRI and PET tumour-imaging probes 200
The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin α v β 3 200
Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia** 200
Design, Synthesis and Biological Evaluation of Novel cRGD-Paclitaxel Conjugates for Integrin-Assisted Drug Delivery 198
Synthesis and biological evaluation of new RGD-camptothecin conjugates bearing disulfide linkers 198
Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I : synthesis 197
A NMR STUDY OF SMAC MIMICS TARGETING BOTH THE BIR2 AND BIR3 DOMAINS IN XIAP PROTEIN. 197
Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists 194
Synthesis of multimeric integrin ligands for the selective tumor-targeted delivery of cytotoxic drugs 190
Ciclopepeptidi ibridi contenenti amminoacidi cicloalcanici, e loro preparazione ed uso 188
RGD-based peptides targheting αIIbβ3 and αvβ3 integrin receptors: an NMR point of view 187
Nonpeptide Integrin Antagonists : RGD Mimetics Incorporating Substituted Azabicycloalkanes as Amino Acid Replacements 185
Synthesis and Conformational Studies of Peptidomimetics Containing a New Bifunctional Diketopiperazine Scaffold Acting as a beta-Hairpin Inducer 184
A combination of Metadynamics and docking calculations rationalizes the effects induced by N-Methylation on RGD-cyclopeptides integrin affinity 184
Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alpha(V)beta(3)/alpha(V)beta(5) integrin dual binders 183
Biological and molecular properties of a new alpha(v)beta(3)/alpha(v)beta(5) integrin antagonist 183
RGD cyclopeptide equipped with a lysine-engaging salicylaldehyde shows enhanced integrin affinity and cell detachment potency 182
Design and synthesis of potent integrin ligands containing a bifunctional diketopiperazine scaffold 181
An integrated computational and NMR study of the first peptidimimetic inhibitors of cadherin homophilic interaction 181
Identification of New L-Fucosyl and L-Galactosyl Amides as Glycomimetic Ligands of TNF Lectin Domain of BC2L-C from Burkholderia cenocepacia 180
Synthesis of azabicycloalkane amino acid scaffolds as reverse-turn inducer dipeptide mimics 180
Bromine-promoted glycosidation of conformationally superarmed thioglycosides 180
Glycomimetic antagonists of BC2L-C lectin: insights from Molecular Dynamics simulations 179
A fragment-based virtual screening approach to identify e-cadherin lingands 179
Stereoselective synthesis of C-alpha-tetrasubstituted azabicyclo[X.3.0]alkane amino acids 178
Development of a highly selective glycomimetic ligand for L-SIGN: a new tool against SARS-CoV-2 and Ebola viruses 177
Binding of RGD-Peptide Mimics to Living Human Cancer Cells: a NMR Study 177
A Comprehensive NMR Analysis of the Interaction between DKP-RGD Ligands and Membrane Proteins on Intact Cells 176
Insights into molecular bases of cadherin : small ligands interaction by STD : NMR 174
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 172
Targeting protein-protein interactions in cancer with peptidomimetics: insights into ligand conformation and ligand-receptor interactions 172
STD and trNOESY NMR Study of Receptor-Ligand Interactions in Living Cancer Cells 171
Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and αIIbβ3 integrin-rich intact cells by NMR and computational studies 171
Design, synthesis, conformational analysis and application of azabicycloalkane amino acids as constrained dipeptide mimics 169
Cyclic isoDGR peptidomimetics: biological evaluation as integrin antagonists and synthesis of tumor-homing conjugates 169
Stem-Like Cancer Cells in a Dynamic 3D Culture System: A Model to Study Metastatic Cell Adhesion and Anti-Cancer Drugs 169
Cyclic isoDGR peptidomimetics: biological evaluation as integrin antagonists and synthesis of tumor-homing conjugates 168
Towards covalent ligands for the N-terminal domain of the bacterial lectin BC2L-C 167
Synthesis of substituted conformationally constrained 6,5- and 7,5-fused bicyclic lactams as dipeptide mimics 167
CD spectra in the near-UV of VEGF-C analogs to assess peptide conformational stability 167
Targeting integrins alphaVbeta3 and alphaIIbeta3 with RGD peptidomimetics : study of the ligand conformation and of the ligand-receptor interactions 166
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics : Insights from Computational Analyses and Implications for Molecular Design 164
Assessing the influence of electrostatic schemes on molecular dynamics simulations of secondary structure forming peptides 163
Different behavior of cyclic RGD peptidomimetics versus a5b1 and aVb3 integrin-rich cancer cells: NMR and computational analysis 163
A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands 162
Totale 23.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 0 109
2021/20222.138 171 89 77 113 188 213 200 148 160 158 184 437
2022/20232.859 360 311 287 273 268 499 53 211 340 57 128 72
2023/20241.754 75 146 133 78 335 150 73 149 63 161 178 213
2024/20254.754 193 416 136 421 312 198 199 457 316 493 470 1.143
2025/202610.243 1.042 850 1.026 881 912 641 1.243 548 1.070 775 995 260
Totale 32.861